Dr. Lingying Wu
Claim this profileCancer Hospital Chinese Academy of Medical Sciences
Studies Cervical Cancer
Studies Ovarian Cancer
4 reported clinical trials
10 drugs studied
Area of expertise
1Cervical Cancer
Stage IV
2Ovarian Cancer
AKT positive
BRCA1 positive
PI3K positive
More about Lingying Wu
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Lingying Wu has experience with
- Tisotumab Vedotin
- Topotecan
- Vinorelbine
- Gemcitabine
- Pemetrexed
- Irinotecan
Breakdown of trials Lingying Wu has run
Cervical Cancer
Ovarian Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lingying Wu specialize in?
Lingying Wu focuses on Cervical Cancer and Ovarian Cancer. In particular, much of their work with Cervical Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Lingying Wu currently recruiting for clinical trials?
No, Lingying Wu is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lingying Wu has studied deeply?
Yes, Lingying Wu has studied treatments such as Tisotumab Vedotin, Topotecan, Vinorelbine.
What is the best way to schedule an appointment with Lingying Wu?
Apply for one of the trials that Lingying Wu is conducting.
What is the office address of Lingying Wu?
The office of Lingying Wu is located at: Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Other 100021 China. This is the address for their practice at the Cancer Hospital Chinese Academy of Medical Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.